[HTML][HTML] Clopidogrel resistance: the way forward

S Ray - indian heart journal, 2014 - Elsevier
Clopidogrel, a second generation thienopyridine has been the mainstay of ACS (Acute
Coronary Syndrome) treatment for more than a decade. Clopidogrel Resistance has been …

Clopidogrel resistance: The way forward

S Ray - Indian Heart Journal, 2014 - infona.pl
Clopidogrel, a second generation thienopyridine has been the mainstay of ACS (Acute
Coronary Syndrome) treatment for more than a decade. Clopidogrel Resistance has been …

[PDF][PDF] Clopidogrel resistance: The way forward

S Ray - indian heart journal, 2014 - core.ac.uk
Clopidogrel, a second generation thienopyridine has been the mainstay of ACS (Acute
Coronary Syndrome) treatment for more than a decade. Clopidogrel Resistance has been …

[HTML][HTML] Clopidogrel resistance: The way forward

S Ray - Indian Heart Journal, 2014 - ncbi.nlm.nih.gov
Clopidogrel, a second generation thienopyridine has been the mainstay of ACS (Acute
Coronary Syndrome) treatment for more than a decade. Clopidogrel Resistance has been …

Clopidogrel resistance: the way forward.

S Ray - Indian Heart Journal, 2014 - europepmc.org
Clopidogrel, a second generation thienopyridine has been the mainstay of ACS (Acute
Coronary Syndrome) treatment for more than a decade. Clopidogrel Resistance has been …

[PDF][PDF] Clopidogrel resistance: The way forward

S Ray - indian heart journal, 2014 - cyberleninka.org
Clopidogrel, a second generation thienopyridine has been the mainstay of ACS (Acute
Coronary Syndrome) treatment for more than a decade. Clopidogrel Resistance has been …

Clopidogrel resistance: the way forward

S Ray - Indian heart journal, 2014 - pubmed.ncbi.nlm.nih.gov
Clopidogrel, a second generation thienopyridine has been the mainstay of ACS (Acute
Coronary Syndrome) treatment for more than a decade. Clopidogrel Resistance has been …

Clopidogrel resistance: the way forward.

S Ray - Indian Heart Journal, 2014 - europepmc.org
Clopidogrel, a second generation thienopyridine has been the mainstay of ACS (Acute
Coronary Syndrome) treatment for more than a decade. Clopidogrel Resistance has been …